JB CHEMICALS & PHARMACEUTICALS Financial Statement Analysis
|
||
|
The Revenues of JB CHEMICALS & PHARMACEUTICALS have increased by 29.91% YoY .
The Earnings Per Share (EPS) of JB CHEMICALS & PHARMACEUTICALS has decreased by -32.77 % YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
JB CHEMICALS & PHARMACEUTICALS Last 5 Annual Financial Results
[BOM: 506943|NSE : JBCHEPHARM]
| Consolidated | Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 |
|---|---|---|---|---|---|
| Revenues | ₹3,149 Cr | ₹2,424 Cr | ₹2,043 Cr | ₹1,775 Cr | ₹1,643 Cr |
| Expenses | ₹2,454 Cr | ₹1,882 Cr | ₹1,486 Cr | ₹1,397 Cr | ₹1,337 Cr |
| Operating Profit (Excl OI) | ₹696 Cr | ₹543 Cr | ₹556 Cr | ₹378 Cr | ₹306 Cr |
| Other Income | ₹9.94 Cr | ₹40 Cr | ₹117 Cr | ₹51 Cr | ₹41 Cr |
| Interest | ₹36 Cr | ₹5.12 Cr | ₹7.24 Cr | ₹3.26 Cr | ₹4.65 Cr |
| Depreciation | ₹114 Cr | ₹73 Cr | ₹69 Cr | ₹66 Cr | ₹56 Cr |
| Profit Before Tax | ₹555 Cr | ₹505 Cr | ₹597 Cr | ₹349 Cr | ₹287 Cr |
| Profit After Tax | ₹410 Cr | ₹386 Cr | ₹449 Cr | ₹272 Cr | ₹194 Cr |
| Consolidated Net Profit | ₹410 Cr | ₹385 Cr | ₹448 Cr | ₹272 Cr | ₹193 Cr |
| Earnings Per Share (Rs) | ₹35.61 | ₹52.97 | ₹49.86 | ₹57.96 | ₹35.20 |
| PAT Margin (%) | 15.33 | 12.54 | 15.51 | 21.96 | 15.35 |
| ROE(%) | 21.49 | 18.51 | 19.89 | 27.64 | 18.69 |
| ROCE(%) | 25.23 | 22.79 | 25.48 | 36.53 | 23.71 |
| Total Debt/Equity(x) | 0.13 | 0.23 | 0.01 | 0.02 | 0.02 |
Key Financials |
||
| Market Cap | : | ₹ 25,106.3 Cr |
| Revenue (TTM) | : | ₹ 3,918.0 Cr |
| Net Profit(TTM) | : | ₹ 659.6 Cr |
| EPS (TTM) | : | ₹ 42.3 |
| P/E (TTM) | : | 38.1 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| JB CHEMICALS & PHARMACEUTICALS | -1.5% | -7.8% | -6.6% |
| SUN PHARMACEUTICAL INDUSTRIES | -0.4% | -0.9% | 4.8% |
| DIVIS LABORATORIES | -0.7% | 1.6% | 50.2% |
| CIPLA | -1.7% | -1.1% | -2.3% |
| TORRENT PHARMACEUTICALS | -1.1% | 1.6% | 13.7% |
| DR REDDYS LABORATORIES | -4.3% | -8% | -4.4% |
| MANKIND PHARMA | 6.8% | 8% | 20.9% |
| ZYDUS LIFESCIENCES | -1.9% | 0.1% | -16.5% |
| LUPIN | -4.3% | -6.4% | 4.6% |
JB CHEMICALS & PHARMACEUTICALS Revenues
[BOM: 506943|NSE : JBCHEPHARM]
| Y-o-Y | 29.91 % |
| 5 Yr CAGR | 17.66 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2024 | ₹3,149 Cr | 29.91 | |
| Mar2023 | ₹2,424 Cr | 18.69 | |
| Mar2022 | ₹2,043 Cr | 15.09 | |
| Mar2021 | ₹1,775 Cr | 8.00 | |
| Mar2020 | ₹1,643 Cr | - | |
JB CHEMICALS & PHARMACEUTICALS Operating Profit
[BOM: 506943|NSE : JBCHEPHARM]
| Y-o-Y | 28.22 % |
| 5 Yr CAGR | 22.81 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2024 | ₹696 Cr | 28.22 | |
| Mar2023 | ₹543 Cr | -2.44 | |
| Mar2022 | ₹556 Cr | 47.30 | |
| Mar2021 | ₹378 Cr | 23.45 | |
| Mar2020 | ₹306 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | -1.30 % |
| 5 Yr CAGR | 4.38 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2024 | 22.09% | -1.30 | |
| Mar2023 | 22.38% | -17.81 | |
| Mar2022 | 27.23% | 27.96 | |
| Mar2021 | 21.28% | 14.35 | |
| Mar2020 | 18.61% | - | |
JB CHEMICALS & PHARMACEUTICALS Profit After Tax
[BOM: 506943|NSE : JBCHEPHARM]
| Y-o-Y | 6.35 % |
| 5 Yr CAGR | 20.64 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2024 | ₹410 Cr | 6.35 | |
| Mar2023 | ₹385 Cr | -13.98 | |
| Mar2022 | ₹448 Cr | 64.66 | |
| Mar2021 | ₹272 Cr | 40.62 | |
| Mar2020 | ₹193 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | 22.25 % |
| 5 Yr CAGR | -0.03 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2024 | 15.33 % | 22.25 | |
| Mar2023 | 12.54 % | -19.15 | |
| Mar2022 | 15.51 % | -29.37 | |
| Mar2021 | 21.96 % | 43.06 | |
| Mar2020 | 15.35 % | - | |
JB CHEMICALS & PHARMACEUTICALS Earnings Per Share (EPS)
[BOM: 506943|NSE : JBCHEPHARM]
| Y-o-Y | -32.77 % |
| 5 Yr CAGR | 0.29 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2024 | ₹36 | -32.77 | |
| Mar2023 | ₹53 | 6.24 | |
| Mar2022 | ₹50 | -13.98 | |
| Mar2021 | ₹58 | 64.66 | |
| Mar2020 | ₹35 | - | |
JB CHEMICALS & PHARMACEUTICALS Return on Capital Employed (ROCE)
[BOM: 506943|NSE : JBCHEPHARM]
| Y-o-Y | 10.71 % |
| 5 Yr CAGR | 1.57 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2024 | 25.23% | 10.71 | |
| Mar2023 | 22.79% | -10.56 | |
| Mar2022 | 25.48% | -30.25 | |
| Mar2021 | 36.53% | 54.07 | |
| Mar2020 | 23.71% | - | |
JB CHEMICALS & PHARMACEUTICALS Share Price vs Sensex
| Current Share Price | : | ₹1,608.4 |
| Current MarketCap | : | ₹ 25,106.3 Cr |
| Updated EOD on | : | Jul 11,2025 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| JB CHEMICALS & PHARMACEUTICALS | -1.5% |
-7.8% |
-6.6% |
| SENSEX | -1.1% |
-0% |
3.2% |
JB CHEMICALS & PHARMACEUTICALS related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| BSE ALLCAP | 6.4% | 8.9% | 7.5% |
| BSE MIDSMALLCAP | 4.7% | 9% | 8.4% |
| BSE 500 SHARIAH | 4.3% | 4.3% | 1.1% |
| BSE SMALLCAP | -0.6% | 0.4% | 0.8% |
| BSE 250 SMALLCAP INDEX | -0.7% | 0.8% | -1.2% |
| NSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| NIFTY MNC | 0.1% | 1% | -6.2% |
| NIFTY SMALLCAP250 QUALITY 50 | -0.4% | -0.2% | -1.2% |
| NIFTY SMALLCAP 250 | -0.7% | 0.7% | -0.1% |
| NIFTY 500 EQUAL WEIGHT | -0.7% | -0.3% | -0.3% |
| NIFTY PHARMA | -0.7% | 0.8% | 9.4% |
You may also like the below Video Courses
FAQ about JB CHEMICALS & PHARMACEUTICALS Financials
How the annual revenues of JB CHEMICALS & PHARMACEUTICALS have changed ?
The Revenues of JB CHEMICALS & PHARMACEUTICALS have increased by 29.91% YoY .
How the Earnings per Share (EPS) of JB CHEMICALS & PHARMACEUTICALS have changed?
The Earnings Per Share (EPS) of JB CHEMICALS & PHARMACEUTICALS has decreased by -32.77 % YoY .
Check out Intrinsic Value of Peers of JB CHEMICALS & PHARMACEUTICALS
Compare Stock Analytics of Peers of JB CHEMICALS & PHARMACEUTICALS
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs
